{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:04Z","timestamp":1786369084137,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-10-LABX-77-01"],"award-info":[{"award-number":["ANR-10-LABX-77-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52363-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:14:56Z","timestamp":1780074896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers"],"prefix":"10.1038","volume":"16","author":[{"given":"Yves","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Candotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Hardel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lany","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris P.","family":"Hejblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lacabaratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Cardinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Centlivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ANRS VRI06 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Agyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motolete","family":"Alaba Tanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raida","family":"Ben Rayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahina","family":"Cheref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Christinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decoville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Desvall\u00e9es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harouna","family":"Diombera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Favreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Foucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapia","family":"Gonzalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Hanot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Hocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jousseaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kiehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Krief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lachatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Laumond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Levoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liem Binh","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Mehawej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Parfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Surgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tommasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Verlinde-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Voidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"23","key":"52363_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361(23), 2209\u201320 (2009).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"52363_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075665","volume":"8","author":"R Gottardo","year":"2013","unstructured":"Gottardo, R. et al. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PLoS One. 8(9), e75665 (2013).","journal-title":"PLoS One."},{"issue":"14","key":"52363_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366(14), 1275\u201386 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"52363_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nbt.3187","volume":"33","author":"L Lin","year":"2015","unstructured":"Lin, L. et al. COMPASS identifies T-cell subsets correlated with clinical outcomes. Nat Biotechnol. 33(6), 610\u20136 (2015).","journal-title":"Nat Biotechnol."},{"issue":"11","key":"52363_CR5","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1172\/JCI126391","volume":"129","author":"SD Neidich","year":"2019","unstructured":"Neidich, S. D. et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. J. Clin. Invest. 129(11), 4838\u201349 (2019).","journal-title":"J. Clin. Invest."},{"issue":"7","key":"52363_CR6","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/S2352-3018(18)30071-7","volume":"5","author":"LG Bekker","year":"2018","unstructured":"Bekker, L. G. et al. Subtype C ALVAC-HIV and bivalent subtype C gp120\/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1\/2 trial. Lancet HIV. 5(7), e366\u2013e78 (2018).","journal-title":"Lancet HIV."},{"issue":"2","key":"52363_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006182","volume":"13","author":"D Easterhoff","year":"2017","unstructured":"Easterhoff, D. et al. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. PLoS Pathog. 13(2), e1006182 (2017).","journal-title":"PLoS Pathog."},{"issue":"2","key":"52363_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003038","volume":"17","author":"F Laher","year":"2020","unstructured":"Laher, F. et al. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: a randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120\/MF59 vaccines. PLoS Med. 17(2), e1003038 (2020).","journal-title":"PLoS Med."},{"issue":"9","key":"52363_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003319","volume":"4","author":"V Naicker","year":"2024","unstructured":"Naicker, V. et al. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120\/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial. PLoS. Glob. Public. Health. 4(9), e0003319 (2024).","journal-title":"PLoS. Glob. Public. Health."},{"issue":"4","key":"52363_CR10","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S2352-3018(19)30406-0","volume":"7","author":"P Pitisuttithum","year":"2020","unstructured":"Pitisuttithum, P. et al. Late boosting of the RV144 regimen with AIDSVAX B\/E and ALVAC-HIV in HIV-uninfected Thai volunteers: A double-blind, randomised controlled trial. The Lancet HIV 7(4), e238\u2013e48 (2020).","journal-title":"The Lancet HIV"},{"issue":"5","key":"52363_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011359","volume":"19","author":"LD Williams","year":"2023","unstructured":"Williams, L. D. et al. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response. PLoS Pathog. 19(5), e1011359 (2023).","journal-title":"PLoS Pathog."},{"key":"52363_CR12","doi-asserted-by":"crossref","unstructured":"Levy Y, Moog C, Wiedemann A, Launay O, Candotti F, Hardel L, et al. Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06). EClinicalMedicine. 77:102845. (2024).","DOI":"10.1016\/j.eclinm.2024.102845"},{"issue":"1","key":"52363_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12883-6","volume":"7","author":"LM Mayr","year":"2017","unstructured":"Mayr, L. M. et al. Non-neutralizing antibodies targeting the V1V2 domain of HIV exhibit strong antibody-dependent cell-mediated cytotoxic activity. Sci. Rep. 7(1), 12655 (2017).","journal-title":"Sci. Rep."},{"issue":"7","key":"52363_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180720","volume":"12","author":"LG Perez","year":"2017","unstructured":"Perez, L. G. et al. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144. PLoS One. 12(7), e0180720 (2017).","journal-title":"PLoS One."},{"issue":"4","key":"52363_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","volume":"12","author":"DR Burton","year":"2012","unstructured":"Burton, D. R. et al. A blueprint for HIV vaccine discovery. Cell Host Microbe. 12(4), 396\u2013407 (2012).","journal-title":"Cell Host Microbe."},{"key":"52363_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","volume":"34","author":"DR Burton","year":"2016","unstructured":"Burton, D. R. & Hangartner, L. Broadly neutralizing antibodies to HIV and their role in vaccine design. Annu. Rev. Immunol. 34, 635\u201359 (2016).","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"52363_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12517","volume":"275","author":"BF Haynes","year":"2017","unstructured":"Haynes, B. F. & Mascola, J. R. The quest for an antibody-based HIV vaccine. Immunol. Rev. 275(1), 5\u201310 (2017).","journal-title":"Immunol. Rev."},{"issue":"7","key":"52363_CR18","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.4049\/jimmunol.1500527","volume":"196","author":"AJ Hessell","year":"2016","unstructured":"Hessell, A. J. et al. Achieving potent autologous neutralizing antibody responses against tier 2 HIV-1 viruses by strategic selection of envelope immunogens. J. Immunol. 196(7), 3064\u201378 (2016).","journal-title":"J. Immunol."},{"issue":"6","key":"52363_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","volume":"46","author":"M Pauthner","year":"2017","unstructured":"Pauthner, M. et al. Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches. Immunity. 46(6), 1073\u201388 (2017).","journal-title":"Immunity."},{"key":"52363_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejpb.2022.10.007","volume":"181","author":"D Peterhoff","year":"2022","unstructured":"Peterhoff, D. et al. Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells. Eur. J. Pharm. Biopharm. 181, 88\u2013101 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6244","key":"52363_CR21","doi-asserted-by":"publisher","first-page":"aac4223","DOI":"10.1126\/science.aac4223","volume":"349","author":"RW Sanders","year":"2015","unstructured":"Sanders, R. W. et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science. 349(6244), aac4223 (2015).","journal-title":"Science."},{"issue":"3","key":"52363_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1586\/14760584.2016.1129905","volume":"15","author":"K Sliepen","year":"2016","unstructured":"Sliepen, K. & Sanders, R. W. HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies. Expert Rev. Vaccines 15(3), 349\u201365 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"52363_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105479","volume":"111","author":"L Nguema","year":"2025","unstructured":"Nguema, L. et al. Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8(+) T cells. EBioMedicine 111, 105479 (2025).","journal-title":"EBioMedicine"},{"issue":"1","key":"52363_CR24","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/s41467-021-25382-0","volume":"12","author":"R Marlin","year":"2021","unstructured":"Marlin, R. et al. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat. Commun. 12(1), 5215 (2021).","journal-title":"Nat. Commun."},{"issue":"12","key":"52363_CR25","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1016\/S2352-3018(25)00195-X","volume":"12","author":"SP Buchbinder","year":"2025","unstructured":"Buchbinder, S. P. et al. Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706\/HPX3002\/Mosaico): A global, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet HIV 12(12), e823\u2013e35 (2025).","journal-title":"Lancet HIV"},{"key":"52363_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","volume":"409","author":"M Sarzotti-Kelsoe","year":"2014","unstructured":"Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods. 409, 131\u201346 (2014).","journal-title":"J. Immunol. Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52363-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:06:30Z","timestamp":1786367190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52363-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52363"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52363-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors S.Z., G.Z., and Y.L., are named inventors on patent applications based on this work held by Inserm Transfert. J-D.L. declares having received remuneration by the Global HIV Vaccine Enterprise. The remaining authors declare no competing interests. Inserm Transfert provided a license for CD40 targeting vaccines to the biotech company EnnoDC (LinKinVax).","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24659"}}